Which Biotechs Enjoyed A 'JPM Jump' - And Which Lost Out?
Executive Summary
As participants from this year’s J.P. Morgan Healthcare conference recover from the torrent of new information they were exposed to, Scrip explores which biotechs saw a sustainable shift in their valuations.